REVIVA PHARMACEUTICALS HOLDINGS, INC. — All Filings
395 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
25-NSE
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
NT 10-K
POS AM
POS EX
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001649553-26-000036 | Mar 25, 2026 | — |
| SCHEDULE 13D/A | — | 0001493152-26-012362 | Mar 24, 2026 | — |
| 4 | FORM 4 | 0001437749-26-009258 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001437749-26-009260 | Mar 20, 2026 | Mar 18, 2026 |
| 8-K | FORM 8-K | 0001437749-26-009063 | Mar 19, 2026 | Mar 18, 2026 |
| 424B5 | FORM 424B5 | 0001437749-26-009062 | Mar 19, 2026 | — |
| 424B5 | FORM 424B5 | 0001437749-26-008843 | Mar 18, 2026 | — |
| 8-K | FORM 8-K | 0001437749-26-006991 | Mar 5, 2026 | Mar 4, 2026 |
| SCHEDULE 13G/A | — | 0000921895-26-000468 | Feb 17, 2026 | — |
| 8-K | FORM 8-K | 0001437749-26-001913 | Jan 23, 2026 | Jan 20, 2026 |
| SCHEDULE 13G/A | — | 0001104659-26-004596 | Jan 16, 2026 | — |
| 8-K | FORM 8-K | 0001437749-25-038602 | Dec 23, 2025 | Dec 18, 2025 |
| SCHEDULE 13D/A | — | 0001493152-25-028783 | Dec 22, 2025 | — |
| 4 | FORM 4 | 0001437749-25-038445 | Dec 19, 2025 | Dec 18, 2025 |
| 4 | FORM 4 | 0001437749-25-038444 | Dec 19, 2025 | Dec 18, 2025 |
| 4 | FORM 4 | 0001437749-25-038446 | Dec 19, 2025 | Dec 18, 2025 |
| 4 | FORM 4 | 0001437749-25-038443 | Dec 19, 2025 | Dec 18, 2025 |
| 25-NSE | — | 0001354457-25-001259 | Dec 12, 2025 | — |
| DEFA14A | FORM DEFA14A | 0001437749-25-037033 | Dec 5, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-034827 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001437749-25-034846 | Nov 13, 2025 | — |
| ARS | ARS | 0001437749-25-033032 | Nov 4, 2025 | Dec 31, 2024 |
| DEF 14A | FORM DEF 14A | 0001437749-25-033023 | Nov 4, 2025 | Dec 18, 2025 |
| DEFA14A | FORM DEFA14A | 0001437749-25-033030 | Nov 4, 2025 | — |
| PRE 14A | FORM PRE 14A | 0001437749-25-031730 | Oct 24, 2025 | Dec 18, 2025 |
| 8-K | FORM 8-K | 0001437749-25-031278 | Oct 17, 2025 | Oct 14, 2025 |
| SCHEDULE 13G | — | 0000921895-25-002634 | Sep 29, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-029951 | Sep 26, 2025 | — |
| SCHEDULE 13D/A | — | 0001493152-25-014806 | Sep 24, 2025 | — |
| SCHEDULE 13D/A | — | 0001437749-25-029807 | Sep 24, 2025 | — |
| 424B5 | FORM 424B5 | 0001437749-25-029530 | Sep 19, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-029531 | Sep 19, 2025 | Sep 18, 2025 |
| 424B5 | FORM 424B5 | 0001437749-25-029398 | Sep 18, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-026971 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001649553-25-000160 | Aug 14, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-003637 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-012270 | Aug 14, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-026967 | Aug 14, 2025 | Jun 30, 2025 |
| SCHEDULE 13D/A | — | 0001641172-25-017411 | Jul 1, 2025 | — |
| SCHEDULE 13G | — | 0001649553-25-000118 | Jul 1, 2025 | — |
| SCHEDULE 13D/A | — | 0001437749-25-021746 | Jul 1, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-021361 | Jun 26, 2025 | — |
| 424B5 | FORM 424B5 | 0001437749-25-021353 | Jun 26, 2025 | — |
| 424B5 | FORM 424B5 | 0001437749-25-021260 | Jun 25, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-019716 | Jun 6, 2025 | Jun 3, 2025 |
| 8-K | FORM 8-K | 0001437749-25-019062 | Jun 2, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-018972 | May 30, 2025 | — |
| 424B5 | FORM 424B5 | 0001437749-25-019011 | May 30, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-007880 | May 15, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-017191 | May 15, 2025 | Mar 31, 2025 |